Source: New Kerala 6/5/2006
Metabolife successor wants to settle suits
In a bankruptcy court filing, San Diego-based MII Liquidation Inc. proposed using the $130.4 million in insurance proceeds to settle 21 suits and avoid a trial.
Approving the settlements and setting up streamlined procedures for future settlements "is in the best interest of creditors and the estates because claims are being resolved in an expeditious and cost-effective manner," The Wall Street Journal reported of MII's request.
After settling the suits, MII said it would have $57.1 million remaining in coverage through Evanston Insurance Co. and National Union Fire Insurance Co. of Pittsburgh.
Related News
-
Michael Ellis Releases Metabolife Book
"The Metabolife Story: The Rape of Cinderella" (www.themjellisgroup.com) represents author and former CEO Michael Ellis' detailed account of the rise and eventual fall of Metabolife, one of the most successful, yet unfairly characterized dietary supplement companies in history. This book finally rev... Read More...Metabolife Dieting Press Release
Holding on to unhealthy fat after an initialweight loss happens to everyone. Even top celebrities' recurring battlewith weight has been well documented in the press. This yo-yo tendencymakes the self promise to lose weight one of the top New Year's pledges andkeeps gyms in business when resoluteness... Read More...Metabolife in Newsweek
So you're feeling a little thick around the middle and you've heard enough about abstinence and exercise. Wouldn't it be nice if you could pop a pill, stretch out in the BarcaLounger and incinerate calories like a long-distance runner? That's the idea behind a hot herbal supplement called Metabolife... Read More...Metabolife Launches Two Stage Weight Management Program
Metabolife, a weight management industry pioneer that successfully helped millions of people lose weight, is back on shelves with a new two-stage supplement program and online support services. The program includes the newly reformulated flagship Metabolife Ultra which is based on clinically-tested ... Read More...
